183 related articles for article (PubMed ID: 33230474)
1. LINC00675 Suppresses Cell Proliferation and Migration via Downregulating the H3K4me2 Level at the SPRY4 Promoter in Gastric Cancer.
Pan Y; Fang Y; Xie M; Liu Y; Yu T; Wu X; Xu T; Ma P; Shu Y
Mol Ther Nucleic Acids; 2020 Dec; 22():766-778. PubMed ID: 33230474
[TBL] [Abstract][Full Text] [Related]
2. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC00675 enhances phosphorylation of vimentin on Ser83 to suppress gastric cancer progression.
Zeng S; Xie X; Xiao YF; Tang B; Hu CJ; Wang SM; Wu YY; Dong H; Li BS; Yang SM
Cancer Lett; 2018 Jan; 412():179-187. PubMed ID: 29107103
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA Linc00675 suppresses cell proliferation and metastasis in colorectal cancer via acting on miR-942 and Wnt/β-catenin signaling.
Shan Z; An N; Qin J; Yang J; Sun H; Yang W
Biomed Pharmacother; 2018 May; 101():769-776. PubMed ID: 29524886
[TBL] [Abstract][Full Text] [Related]
6. GFI1-Mediated Upregulation of LINC00675 as a ceRNA Restrains Hepatocellular Carcinoma Metastasis by Sponging miR-942-5p.
Lu L; Li S; Zhang Y; Luo Z; Chen Y; Ma J; Chen P; Wang W; Pu J; Wang J
Front Oncol; 2020; 10():607593. PubMed ID: 33489916
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA LINC00675 inhibits tumorigenesis and EMT via repressing Wnt/β-catenin signaling in esophageal squamous cell carcinoma.
Zhong YB; Shan AJ; Lv W; Wang J; Xu JZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8288-8297. PubMed ID: 30556869
[TBL] [Abstract][Full Text] [Related]
8. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of LSD1 promotes migration and invasion in gastric cancer through facilitating EMT.
Zhang J; Zhao D; Li Q; Du X; Liu Y; Dai X; Hong L
Cancer Manag Res; 2019; 11():4481-4491. PubMed ID: 31191010
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and promotes tumorigenesis in gastric cancer.
Peng W; Wu G; Fan H; Wu J; Feng J
Tumour Biol; 2015 Sep; 36(9):6751-8. PubMed ID: 25835973
[TBL] [Abstract][Full Text] [Related]
11. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.
Liu Z; Chen Z; Fan R; Jiang B; Chen X; Chen Q; Nie F; Lu K; Sun M
Mol Cancer; 2017 Apr; 16(1):82. PubMed ID: 28441948
[TBL] [Abstract][Full Text] [Related]
12. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
[TBL] [Abstract][Full Text] [Related]
13. Identification of downstream metastasis-associated target genes regulated by LSD1 in colon cancer cells.
Chen J; Ding J; Wang Z; Zhu J; Wang X; Du J
Oncotarget; 2017 Mar; 8(12):19609-19630. PubMed ID: 28121627
[TBL] [Abstract][Full Text] [Related]
14. LINC00675 is a prognostic factor and regulates cell proliferation, migration and invasion in glioma.
Li Z; Li Y; Wang Q
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061182
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
16. LSD1 regulates the FOXF2-mediated Wnt/β-catenin signaling pathway by interacting with Ku80 to promote colon cancer progression.
Liu Z; Xiao J; Wang N; Ding J
Am J Cancer Res; 2022; 12(8):3693-3712. PubMed ID: 36119820
[TBL] [Abstract][Full Text] [Related]
17. LSD1 promotes S-phase entry and tumorigenesis via chromatin co-occupation with E2F1 and selective H3K9 demethylation.
He Y; Zhao Y; Wang L; Bohrer LR; Pan Y; Wang L; Huang H
Oncogene; 2018 Jan; 37(4):534-543. PubMed ID: 28991226
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of lncRNA LINC00460 Facilitates GC Progression through Epigenetically Silencing CCNG2 by EZH2/LSD1 and Indicates Poor Outcomes.
Yang J; Lian Y; Yang R; Lian Y; Wu J; Liu J; Wang K; Xu H
Mol Ther Nucleic Acids; 2020 Mar; 19():1164-1175. PubMed ID: 32059342
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA HOXA-AS2 represses P21 and KLF2 expression transcription by binding with EZH2, LSD1 in colorectal cancer.
Ding J; Xie M; Lian Y; Zhu Y; Peng P; Wang J; Wang L; Wang K
Oncogenesis; 2017 Jan; 6(1):e288. PubMed ID: 28112720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
